Cimento a base de β-fosfato tricálcico em defeitos ósseos produzidos no crânio de coelhos

• Ano de defesa: 2013
• Autor(a) principal: Dornas, Raul Felipe
• Orientador(a): Borges, Andrea Pacheco Batista
• Banca de defesa: Valente, Fabrício Luciani , Reis, Emily Correna Carlo , Bicalho, Sheila Maria de Castro Máximo
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de Viçosa
• Programa de Pós-Graduação: Mestrado em Medicina Veterinária
• Departamento: Biotecnologia, diagnóstico e controle de doenças; Epidemiologia e controle de qualidade de prod. de
• País: BR
• Palavras-chave em Português: Biomaterial; Composito; Cranioplastia
• Palavras-chave em Inglês: Biomaterial; Composito; Cranioplasty
• Área do conhecimento CNPq: CNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIA::CLINICA E CIRURGIA ANIMAL::CLINICA CIRURGICA ANIMAL
• Link de acesso: http://locus.ufv.br/handle/123456789/5135

The loss of bone tissue is an important problem both in human and in veterinary medicines. For cranial bone defects, surgical intervention is necessary since, if not correct, these defects result in high number of cerebral lesions and neurological dysfunctions as well as esthetic sequelae. In such context, autogenous and alogenous grafts have given place to resorbable osteoconductive biomaterials. The objective of the present study was to evaluate a bone cement made from a solid phase (β-tricalcium phosphate and calcium sulfate dihydrate) and a liquid one (phosphoric acid 2M). These components were mixed in a stainless steel cube at a proportion of 1:1 and the material while still moldable, was applied in 15mm critical size defects in the cranial bone of rabbits, Scanning electron microscopy of the cement itself showed a complex surface with non-interconnected pores of 19.5±5.92 μm in diameter. Animals were separated in three experimental moments based on the time after surgical procedure (7, 28 and 90 days), comparing to defects that did not receive the material. Hematological and serum biochemistry revealed normal values during the entire experiment. Dehiscence, edema or signs of infection were not observed. In treated animals, alterations were observed on skin (hyperemia and necrosis) and brain (circular lesions of green color with vascular congestion) that evolved to healing at 90 days. These alterations may be related related to a low pH of the biomaterial during the implantation (3.38), resulted from the proportion of liquid:powder used in the present study (1:1). As suggested by computerized tomography and confirmed by histology, new bone formation occurred in control group from the margin of the defect and inside it. In treated group, bone growth was apparently less intense at 90 days when compared to the control one, limited to the margin of the defect and not observed inside it. Osteointegration was confirmed and neither signs of undesirable chronic inflammation nor the formation of a fibrous capsule around the material was observed. Thereby, the biomaterial was characterized as osteoconductor, osteointegrated, degradable in vivo and histologically biocompatible. The alterations in the color of nervous tissue and skin adjacent to the implant, although with no clinical relevance, indicate the need for a modification on the proportion of the biomaterial components. Possibly, reducing the relation liquid:powder may allow its application.